Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

731
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
731
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

786
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
786
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.6K
The pathophysiology of pneumonia involves the following steps:
2.6K
Pneumonia IV: Management01:28

Pneumonia IV: Management

756
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
756
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

318
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
318
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.4K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corticosteroids in immunocompromised ICU patients with pneumonia: risks, evidence, and clinical practice.

Pneumonia (Nathan Qld.)·2026
Same author

Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP).

Critical care medicine·2026
Same author

External Validation of the Long-term Pneumonia Mortality Index in a Low- and Middle-Income Country.

American journal of respiratory and critical care medicine·2026
Same author

Precision antibiotic treatment in intensive care unit-acquired lower respiratory tract infections (ICU-LRTIs): contemporary concepts and future directions.

Expert review of anti-infective therapy·2026
Same author

Letter to perpetual observational study of the clinical and microbiological epidemiology of ventilator-associated pneumonia in Europe.

Critical care (London, England)·2026
Same author

Think beyond the standard: anti-MRSA options in community-acquired pneumonia - Authors' reply.

Lancet (London, England)·2026
Same journal

Monographic Issue on New Concepts in Acute Exacerbations of COPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Bidirectional Clinical Interactions among Exacerbations and Comorbidities in COPD: A Narrative Review.

Seminars in respiratory and critical care medicine·2026
Same journal

Radiological Approach to Severe Respiratory Infections and Pulmonary Complications in Immunocompromised Patients.

Seminars in respiratory and critical care medicine·2026
Same journal

Two Sides of the Same Smoke: Decoding Respiratory Bronchiolitis-Associated Interstitial Lung Disease and Alveolar Macrophage Pneumonia.

Seminars in respiratory and critical care medicine·2026
Same journal

Role of Vaccination in the Prevention of ECOPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Pharmacological Treatment of AECOPD New Perspectives.

Seminars in respiratory and critical care medicine·2026
See all related articles

Related Experiment Video

Updated: Jan 17, 2026

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.4K

Pneumonia after Solid Organ Transplantation.

Paula O Narvaez-Ramirez1, Cristian C Serrano-Mayorga1,2, Ingrid G Bustos1,3

  • 1Critical Care Department, Clínica Universidad de La Sabana, Chía, Colombia.

Seminars in Respiratory and Critical Care Medicine
|September 24, 2025
PubMed
Summary
This summary is machine-generated.

Pneumonia poses a significant threat to solid organ transplant recipients (SOTRs), increasing mortality. Early diagnosis and targeted therapy are crucial for managing these infections in SOTRs.

More Related Videos

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
10:01

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation

Published on: July 10, 2012

21.0K
Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
07:28

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

704

Related Experiment Videos

Last Updated: Jan 17, 2026

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.4K
Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
10:01

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation

Published on: July 10, 2012

21.0K
Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
07:28

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

704

Area of Science:

  • Transplantation Medicine
  • Infectious Diseases
  • Pulmonology

Background:

  • Solid organ transplantation (SOT) has risen globally, increasing the number of SOT recipients (SOTRs).
  • Immunosuppression in SOTRs elevates the risk of infections, particularly pneumonia, a leading cause of death.
  • Pneumonia contributes significantly to morbidity and mortality in SOTRs, with infection timing influencing outcomes.

Purpose of the Study:

  • To review current knowledge on pneumonia in SOTRs, covering epidemiology, risk factors, etiology, and clinical features.
  • To explore temporal infection patterns and challenges in SOTR pneumonia management.
  • To emphasize evidence-based strategies for improving outcomes in SOTRs.

Main Methods:

  • Literature review summarizing existing data on pneumonia in SOTRs.
  • Analysis of temporal trends in infection causes post-transplantation.
  • Discussion of current management guidelines and their limitations.

Main Results:

  • Pneumonia is a major cause of death in SOTRs, with varied etiology based on time post-transplant.
  • Early infections often involve nosocomial or donor pathogens; later infections are frequently community-acquired.
  • Lack of SOT-specific guidelines and limited trials hinder evidence-based management.

Conclusions:

  • Early empirical therapy initiation is vital for improving SOTR outcomes.
  • Timely microbiological diagnosis, antimicrobial stewardship, and targeted therapies are essential.
  • Personalized risk assessment and local data integration can optimize pneumonia management in SOTRs.